The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

DSE:IBNSINA Revenue

The IBN SINA Pharmaceutical Industry had revenue of 3.72B BDT in the quarter ending September 30, 2025, with 34.86% growth. This brings the company's revenue in the last twelve months to 12.84B, up 14.36% year-over-year. In the fiscal year ending June 30, 2025, The IBN SINA Pharmaceutical Industry had annual revenue of 11.88B with 4.51% growth.

• Revenue (ttm): 12.84B
• Revenue Growth: +14.36%
• P/S Ratio: 0.75
• Revenue / Employee: 2.47M
• Employees: 5,200
• Market Cap: 9.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	11.88B	512.67M	4.51%
Jun 30, 2024	11.37B	2.25B	24.61%
Jun 30, 2023	9.13B	645.51M	7.61%
Jun 30, 2022	8.48B	1.10B	14.96%
Jun 30, 2021	7.38B	1.18B	19.13%